PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
Similar ESG score to FBIO's 61.57. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
59.54
Environmental score 1.1-1.2x FBIO's 56.05. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
58.66
Social score 90-95% of FBIO's 64.16. Bill Ackman would demand clear social improvement catalysts.
57.40
Governance score 80-90% of FBIO's 64.50. Walter Schloss would scrutinize management accountability and board independence.